Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling

被引：19
|
作者：
Zhang, Haiyu [1 ]
Ge, Tingting [2 ]
Cui, Xiaoming [1 ]
Hou, Yan [1 ]
Ke, Chaofu [1 ]
Yang, Meng [2 ]
Yang, Kai [1 ]
Wang, Jingtao [1 ]
Guo, Bing [1 ]
Zhang, Fan [1 ]
Lou, Ge [2 ]
Li, Kang [1 ]
机构：
[1] Harbin Med Univ, Dept Epidemiol & Biostat, Harbin 150081, Peoples R China
[2] Harbin Med Univ, Dept Gynecol Oncol, Tumor Hosp, Harbin 150086, Peoples R China
来源：
MOLECULAR BIOSYSTEMS | 2015年 / 11卷 / 02期
基金：
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词：
CHROMATOGRAPHY-MASS-SPECTROMETRY; T-CELL PROLIFERATION; INDOLEAMINE 2,3-DIOXYGENASE; POTENTIAL BIOMARKERS; DENDRITIC CELLS; STAGE-III; TRYPTOPHAN; IDENTIFICATION; INHIBITION; LYSOPHOSPHATIDYLCHOLINE;
D O I：
10.1039/c4mb00407h
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Epithelial ovarian cancer (EOC) is the most lethal of gynecologic malignancies due to the high rate of recurrence and poor prognosis. Predicting the prognosis in patients with EOC is clinically challenging, partly because appropriate biomarkers of recurrence have yet to be explored. In this prospective study, pre-treatment plasma samples were collected from 38 patients with stage III or IV EOC who were subsequently followed up. Ultra-performance liquid chromatography mass spectrometry was used to perform metabolic profiling, which yielded five metabolites that were potential biomarkers for EOC recurrence: L-tryptophan, kynurenine, bilirubin, LysoPC (14 : 0) and LysoPE (18 : 2). A combination of these five potential biomarkers strongly predicted recurrence, the area under the curve being 0.91. In summary, the candidate biomarkers identified in this study may both facilitate clinical prediction of EOC recurrence and prognosis and serve as potential therapeutic targets in patients with EOC.
引用
收藏
页码：516 / 521
页数：6
相关论文
共 50 条
  • [41] Prediction of Epithelial Ovarian Cancer Outcomes With Integration of Genomic Data
    Newtson, Andreea M.
    Devor, Eric J.
    Bosquet, Jesus Gonzalez
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2020, 63 (01) : 92 - 108
  • [42] Plasma profiling reveals a blood-based metabolic fingerprint of obstructive sleep apnea
    Pinilla, Lucia
    Benitez, Ivan D.
    Santamaria-Martos, Fernando
    Targa, Adriano
    Moncusi-Moix, Anna
    Dalmases, Mireia
    Minguez, Olga
    Aguila, Maria
    Jove, Mariona
    Sol, Joaquim
    Pamplona, Reinald
    Barbe, Ferran
    Sanchez-de-la-Torre, Manuel
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 145
  • [43] Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies
    Timms, John F.
    Arslan-Low, Elif
    Kabir, Musarat
    Worthington, Jenny
    Camuzeaux, Stephane
    Sinclair, John
    Szaub, Joanna
    Afrough, Babak
    Podust, Vladimir N.
    Fourkala, Evangelia-Ourania
    Cubizolles, Myriam
    Kronenberg, Florian
    Fung, Eric T.
    Gentry-Maharaj, Aleksandra
    Menon, Usha
    Jacobs, Ian
    PROTEOMICS CLINICAL APPLICATIONS, 2014, 8 (11-12) : 982 - 993
  • [44] Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis
    Kobayashi, Makoto
    Katayama, Hiroyuki
    Irajizad, Ehsan
    Vykoukal, Jody V.
    Fahrmann, Johannes F.
    Kundnani, Deepali L.
    Yu, Chuan-Yih
    Cai, Yining
    Hsiao, Fu Chung
    Yang, Wei-Lei
    Lu, Zhen
    Celestino, Joseph
    Long, James P.
    Do, Kim-Ann
    Lu, Karen H.
    Ladd, Jon J.
    Urban, Nicole
    Bast, Robert C.
    Hanash, Samir M.
    CANCERS, 2020, 12 (02)
  • [45] Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review
    Kobayashi, Hiroshi
    HELIYON, 2022, 8 (11)
  • [46] Potential molecular signatures in epithelial ovarian cancer by genome wide expression profiling
    Wong, Yin-Ling
    Dali, Ahmad Zailani Hatta Mohd
    Rose, Isa Mohamed
    Jamal, Rahman
    Mokhtar, Norfilza Mohd
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (02) : E259 - E268
  • [47] Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: An external validation study of three models using computed tomography
    Rutten, Iris J. G.
    van de Laar, Rafli
    Kruitwagen, Roy F. P. M.
    Bakers, Frans C. H.
    Ploegmakers, Marieke J. M.
    Pappot, Teun W. F.
    Beets-Tan, Regina G. H.
    Massuger, Leon F. A. G.
    Zusterzeel, Petra L. M.
    Van Gorp, Toon
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 22 - 28
  • [48] Metabolic signatures differentiate ovarian from colon cancer cell lines
    Halama, Anna
    Guerrouahen, Bella S.
    Pasquier, Jennifer
    Diboun, Ilhem
    Karoly, Edward D.
    Suhre, Karsten
    Rafii, Arash
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [49] The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer
    Bachmann, Robert
    Rothmund, Ralf
    Kraemer, Bernhard
    Brucker, Sara Y.
    Koenigsrainer, Alfred
    Koenigsrainer, Ingmar
    Beckert, Stefan
    Staebler, Anette
    Phuc NguyenHuu
    Grischke, Eva
    Wallwiener, Diethelm
    Bachmann, Cornelia
    JOURNAL OF INVESTIGATIVE SURGERY, 2015, 28 (03) : 160 - 166
  • [50] Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
    Morrison, Jo
    Haldar, Krishnayan
    Kehoe, Sean
    Lawrie, Theresa A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (08):
12345